Report of first recurrent glioma patients examined with PET-MRI prior to re-irradiation.
Daniel F FleischmannMarcus UnterrainerStefanie CorradiniMaya RottlerStefan FörsterChristian la FougèreTimo SiepmannMarkus SchwaigerPeter BartensteinClaus BelkaNathalie L AlbertMaximilian NiyaziPublished in: PloS one (2019)
PET-MRI provides radiation treatment planning imaging with high spatial and timely conformity for high-grade glioma patients treated with re-RT with potential advancements for target volume delineation. Prospective randomised trials are warranted to further investigate the treatment benefits of PET-MRI based re-RT planning.
Keyphrases
- contrast enhanced
- computed tomography
- high grade
- magnetic resonance imaging
- positron emission tomography
- pet ct
- end stage renal disease
- diffusion weighted imaging
- clinical trial
- pet imaging
- ejection fraction
- newly diagnosed
- chronic kidney disease
- high resolution
- prognostic factors
- peritoneal dialysis
- low grade
- study protocol
- patient reported